KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Long-Term Deferred Tax (2016 - 2023)

Merck (MRK) has disclosed Long-Term Deferred Tax for 14 consecutive years, with $10.2 billion as the latest value for Q2 2023.

  • On a quarterly basis, Long-Term Deferred Tax fell 7.15% to $10.2 billion in Q2 2023 year-over-year; TTM through Jun 2023 was $10.2 billion, a 7.15% decrease, with the full-year FY2022 number at $9.5 billion, down 17.73% from a year prior.
  • Long-Term Deferred Tax was $10.2 billion for Q2 2023 at Merck, down from $10.3 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $11.6 billion in Q4 2021 to a low of $6.8 billion in Q4 2019.
  • A 5-year average of $9.6 billion and a median of $9.7 billion in 2020 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: decreased 19.01% in 2020, then surged 48.7% in 2021.
  • Merck's Long-Term Deferred Tax stood at $6.8 billion in 2019, then skyrocketed by 45.93% to $9.9 billion in 2020, then grew by 17.21% to $11.6 billion in 2021, then fell by 17.73% to $9.5 billion in 2022, then rose by 6.92% to $10.2 billion in 2023.
  • Per Business Quant, the three most recent readings for MRK's Long-Term Deferred Tax are $10.2 billion (Q2 2023), $10.3 billion (Q1 2023), and $9.5 billion (Q4 2022).